Hydrogen Gas Inhalation Improves Fatty Liver Disease in Clinical Trial
- Authors
- Geru Tao, Guangjie Zhang, Wei Chen, Chao Yang, Yazhuo Xue, Guohua Song, Shucun Qin
- Journal
- Journal of Cellular and Molecular Medicine
- Year
- 2022
- DOI
- 10.1111/jcmm.17456
- Study Type
- Human
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Non-Alcoholic Fatty Liver Disease
- Body System
- Hepatic
TL;DR
Breathing in a mix of hydrogen and oxygen gas can help improve liver health in people with a common liver disease linked to obesity and diabetes, possibly by helping liver cells clean up and recycle their own parts.
Key Finding
Hydrogen/oxygen inhalation improved blood lipid levels, liver enzymes, and liver fat content in patients with moderate-severe NAFLD, with the greatest improvements seen in those with more advanced disease.
Summary
This study tested whether breathing a mixture of hydrogen and oxygen gas could help people with non-alcoholic fatty liver disease (NAFLD), a condition where fat builds up in the liver. Forty-three people either received hydrogen/oxygen inhalation or a placebo (fake treatment) for 13 weeks. The researchers found that people who breathed the hydrogen/oxygen mixture showed improvements in blood fat levels, liver enzyme levels, and the amount of fat in their livers on imaging scans, particularly those with moderate to severe disease. The study also included animal experiments suggesting the benefit may work by activating a cellular cleaning process called autophagy.
Practical Takeaway
This early-stage human trial suggests hydrogen/oxygen inhalation may help reduce liver fat in people with NAFLD, particularly those with moderate-severe disease. However, the study was small (43 people) and the full results are not yet published, so more research in larger groups is needed before firm conclusions can be drawn. Anyone with NAFLD should discuss any new treatment with their doctor before trying it.
Abstract (excerpt)
AbstractNon‐alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide with increasing incidence consistent with obesity, type 2 diabetes and cardiovascular diseases. No approved medication was currently available for NAFLD treatment. Molecular hydrogen (H2)…